What is the price target for SMTI stock?
7 analysts have analysed SMTI and the average price target is 36.72 USD. This implies a price increase of 116.38% is expected in the next year compared to the current price of 16.97.
SANARA MEDTECH INC (SMTI) Forecast, Price Target & Analyst Ratings
NASDAQ:SMTI • US79957L1008
Current stock price
16.97 USD
-0.03 (-0.18%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SANARA MEDTECH INC (SMTI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.13
- Revenue Estimate
- 28.458M
Price Target Details & History
Consensus Price Target and Range
Mean target
$36.72
Upside
+ 116.38%
From current price of $16.97 to mean target of $36.72, Based on 7 analyst forecasts
Low
$36.36
Median
$36.72
High
$37.80
Price Target Revisions
1 Month
-10.00%
3 Months
-12.20%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for SMTI. The average price target is 36.72 USD. This implies a price increase of 116.38% is expected in the next year compared to the current price of 16.97.
The average price target has been revised downward by 12.2% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
SMTI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SMTI.
In the previous month the buy percentage consensus was at a similar level.
SMTI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-23 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-27 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-09-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2021-06-30 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.13
- Revenue Estimate
- 28.458M
- Revenue Q2Q
- 21.44%
- EPS Q2Q
- 132.18%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.90%
Revenue (3 Months)
-0.71%
EPS (1 Month)
0.00%
EPS (3 Months)
73.33%
Next Earnings Summary
SMTI is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is 0.13 USD and the consensus revenue estimate is 28.46M USD.
The next earnings revenue estimate has been revised downward by 0.71% in the past 3 months.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.99M 41.78% | 86.672M 33.36% | 103.118M 18.97% | 120.97M 17.31% | 136.07M 12.48% | |
| EBITDA YoY % growth | -540.2K 94.41% | 7.003M 1,396.33% | 13.092M 86.95% | N/A | N/A | |
| EBIT YoY % growth | -4.215M 64.99% | 2.08M 149.34% | 9.146M 339.78% | 14.201M 55.28% | 19.074M 34.31% | |
| Operating Margin | -6.49% | 2.40% | 8.87% | 11.74% | 14.02% | |
| EPS YoY % growth | -0.52 59.86% | -1.14 -119.23% | -0.46 59.47% | 0.66 243.51% | 1.09 64.62% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 132.18% | 0.15 166.52% | 0.17 92.67% | 0.19 115.33% |
| Revenue Q2Q % growth | 28.458M 21.44% | 29.478M 14.12% | 31.008M 17.75% | 32.028M 16.27% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 204K 109.81% | 918K 3,023.57% | 1.224M -58.38% | 3.06M 5.82% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SANARA MEDTECH INC / SMTI Forecast FAQ
When does SANARA MEDTECH INC (SMTI) report earnings?
SANARA MEDTECH INC (SMTI) will report earnings on 2026-05-12.
Can you provide the consensus estimates for SANARA MEDTECH INC next earnings?
The consensus EPS estimate for the next earnings of SANARA MEDTECH INC (SMTI) is 0.13 USD and the consensus revenue estimate is 28.46M USD.